3 withdrawn, 2 completed, 1 terminated, 1 unknown. 7 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Withdrawn 3, Completed 2, Terminated 1, Unknown 1 |
| Phase 2 | 4 | Withdrawn 2, Completed 1, Unknown 1 |
Follow Interferons: new trials by email Literature Review of Interferons trials Research Report on Interferons
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy SV-BR-1-GM Vaccine, Cyclophosphamide, Pembrolizumab - Brain Metastases, Leptomeningeal Metastasis | Phase 1 | Withdrawn | Medical College of Wisconsin | 2026-06-15 | 2026-06-17 | |
| IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma Ipilimumab, Interferon, Interleukin-2 (Aldesleukin) - Melanoma | Phase 1 / Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2011-10-01 | 2012-01-26 | |
| Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease interferon - Hepatitis C Virus | Phase 1 / Phase 2 | Completed | The First Hospital of Jilin University | 80 | 2011-06-01 | 2016-01-26 |
| Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia Influenza Vaccine Trivalent Inactivated (TIV), Pegylated interferon (PEGrIFN-α, Pegasys), Interferon (IFNα, Roferon-A) - Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2011-04-01 | 2012-08-03 | |
| Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis conventional therapy plus MenSC transplantation, Conventional therapy plus placebo treatment - Liver Cirrhosis, Fibrosis | Phase 1 / Phase 2 | Unknown | S-Evans Biosciences Co., Ltd. | 50 | 2010-10-01 | 2012-06-07 |
| Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma recombinant interferon alfa-2b, sodium stibogluconate, SSG & interferon - Cancer | Phase 1 | Terminated | The Cleveland Clinic | 18 | 2005-10-01 | 2018-01-26 |
| Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma recombinant interferon alpha-1b, IFN - Breast Cancer, Kidney Cancer | Phase 1 | Completed | The Cleveland Clinic | 35 | 2001-01-01 | 2015-10-14 |
Melanoma (3) · Sarcoma (2) · Brain Neoplasms (1) · Breast Neoplasms (1) · Digestive System Diseases (1) · Fibrosis (1) · Hepatitis C (1) · Influenza, Human (1) · Kidney Neoplasms (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Liver Cirrhosis (1) · Liver Diseases (1) · Lymphoma (1) · Meningeal Carcinomatosis (1)
M.D. Anderson Cancer Center (2) · The Cleveland Clinic (2) · Medical College of Wisconsin (1) · S-Evans Biosciences Co., Ltd. (1) · The First Hospital of Jilin University (1)
China (2) · United States (2)
Ernest C. Borden, MD (2) · Agop Y. Bedikian, MD,BS (1) · Amar Safdar, MD (1) · Charlie Xiang, Professor (1)
P30CA043703 (2)